Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Radiotherapy mostly uses X-rays for the cancer treatment which uses intense beams of energy to kill cancerous cells. Radiotherapy is also known as Radiation Therapy and Irradiation. It plays vital role in killing of cancerous cell as well as it shrink tumor by the use of high-energy radiation from x-rays, gamma rays, neutrons, protons, and other sources. It works by damaging cells by destroying the genetic material that controls cell division and cell growth. Radiotherapy uses radioactive substances that has ability to travels in the blood to tissues throughout the body. Radiotherapy can be referred as local treatment.
The factors that driving the market growth are growing use of particle therapy for cancer treatment and increasing incidence of cancer & related mortality. Hence the radiotherapy market has been seeing tremendous growth from the past few decades. Higher demand for linear accelerators and particle therapy systems will boosts the market growth in upcoming years. Nevertheless, affordability and accessibility of treatment and complex nature of radiotherapy are the major restraining factor that could hamper the growth of the market.
The COVID 19 outbreak had significant impact on the healthcare market. As the rise in COVID 19 cases, for prevention purpose government has announced lockdown in many countries which lead to postponing of radiotherapy procedures which will affect radiotherapy market. Due to closed manufacturing facilities it will disrupted the supply and production chains. The number of emerging patients towards radiotherapy emergency services which is available in almost all centers are reduced. Due to this scenario, COVID 19 negatively impacted the growth of the overall radiotherapy devices market in 2020.
The study analyses North America radiotherapy market based on product, application, procedure, end users and country.
By the product used in the radiotherapy market is segmented into external beam radiotherapy, internal beam radiotherapy/brachytherapy and systemic radiotherapy. The external beam radiotherapy is sub-segmented into conventional linear accelerators (LINAC), conventional cobalt-60 teletherapy units, and stereotactic advanced electron and particle therapy systems. The internal beam radiography is sub-segmented into seeds, afterloaders, applicators and IORT Systems. The conventional linear accelerators (LINAC) segment accounted for the largest share of the external beam radiotherapy market in 2020.
The radiotherapy market finds has application in the external and internal beam radiotherapy. The external beam radiotherapy is sub-segmented into Prostate Cancer, Breast Cancer, Lung Cancer, Head and Neck Cancer and Colorectal Cancer. The internal beam radiotherapy/brachytherapy applications market is segmented into prostate cancer, gynecological cancer, breast cancer, cervical cancer, penile cancer, and other cancers. The breast cancer segment accounted for the largest market share in 2020 and is likely to witness rapid growth in the coming years. The factors responsible for market growth are growing incidence of breast cancer and increasing volume of diagnostic procedures and treatment for the disease.
Depending on various procedures used in the radiotherapy market are classified into external and internal beam radiotherapy. The external beam radiotherapy is sub-segmented into Image-guided Radiotherapy, Intensity-modulated Radiotherapy, Stereotactic Therapy, Particle Therapy and 3D Conformal Radiotherapy. The image guided radiotherapy (IGRT) segment leads the market in 2020 and is witnessing fastest growth in upcoming years owing to, IGRT involves the use of images taken before and during treatment, which helps in accurately targeting cancerous cells to kill. Due to precise and accurate diagnosis IGRT segment lead the market.
According to the various end users the radiotherapy market is categorized into Hospitals and independent radiotherapy centers. The hospitals segment dominated the market in 2020 and is expected to maintain its dominance during the forecast period 2021-2027. The growing number of cancer cases in all populations and development of new hospitals with radiotherapy services will fuel the market growth.
Country wise, the study is comprised of the key countries such as the Unites States (US), Mexico and Canada. The US held the largest market share of North America market and is likely to dominate the radiotherapy market over the forecast period 2021-2027. The countries such as US, Mexico and Canada, surge rise in demand for radiotherapy market due to rise in prevalence of cancer in all population.
The major key players of market includes Varian Medical Systems, Inc. (US), Elekta (Sweden), Accuray Incorporated (US), Ion Beam Applications SA (Belgium), BD (US), Eckert & Ziegler (Germany), Hitachi Ltd. (Japan), ICAD, Inc. (US), IntraOp Medical, Inc. (US), IsoRay Medical, Inc. (US), Mevion Medical Systems, Inc. (US), Panacea Medical Technologies Pvt. Ltd. (India), P-cure Ltd. (Israel),ViewRay, Inc. (US) and ZEISS Group (Germany)
November 2020: Elekta AB (Sweden) received CE mark for the Elekta Harmony linear accelerator, clearing the technology for commercial sales in Europe.
April 2020: Elekta AB (Sweden) launched Geneva, the first universal gynecological applicator for brachytherapy. Geneva applicator is CE-marked and has received US FDA 510(k) clearance. It is used for cervical cancer up to stage IIB.
June 2020: Accuray Incorporated (US) launched the CyberKnife S7 System, an innovative device combining speed, advanced precision, and real-time AI-driven motion tracking and synchronization treatment delivery for all stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments.
The study analyses North America radiotherapy market product, application, procedure, end users and country. Radiotherapy plays key role in treating cancer by radiating the tumor cells and destructing its growth and division procedure. The primary growth factors behind the market growth are technological advancements and expansion of the target patient population. The application areas in radiotherapy market are prostate cancer, breast cancer, lung cancer, head and neck Cancer and colorectal cancer. Besides this, increasing applications of radiotherapy and increasing R&D funding for pharma and biotech companies will boosts the market growth. Improving healthcare infrastructure in many regions will drive radiotherapy market growth in upcoming years. The rise in adoption of radiotherapy products in all over the population is expected to impede market growth over the forecast period 2021-2027. Country wise study comprises countries like US, Mexico and Canada. The US held the largest market share of North America radiotherapy market and is likely to dominate the market over the estimated time frame.
Why to buy this report:
